JPWO2020234300A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020234300A5 JPWO2020234300A5 JP2021564088A JP2021564088A JPWO2020234300A5 JP WO2020234300 A5 JPWO2020234300 A5 JP WO2020234300A5 JP 2021564088 A JP2021564088 A JP 2021564088A JP 2021564088 A JP2021564088 A JP 2021564088A JP WO2020234300 A5 JPWO2020234300 A5 JP WO2020234300A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- domain
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175413.4 | 2019-05-20 | ||
| EP19175413 | 2019-05-20 | ||
| PCT/EP2020/063973 WO2020234300A1 (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533318A JP2022533318A (ja) | 2022-07-22 |
| JPWO2020234300A5 true JPWO2020234300A5 (ru) | 2023-05-31 |
Family
ID=66685352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564088A Pending JP2022533318A (ja) | 2019-05-20 | 2020-05-19 | 気道感染の治療または予防のためのサブユニットワクチン |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20220185847A1 (ru) |
| EP (1) | EP3972639A1 (ru) |
| JP (1) | JP2022533318A (ru) |
| KR (1) | KR20220010478A (ru) |
| CN (1) | CN114127101A (ru) |
| AU (1) | AU2020277661A1 (ru) |
| BR (1) | BR112021021637A2 (ru) |
| CA (1) | CA3138064A1 (ru) |
| CL (1) | CL2021002819A1 (ru) |
| CO (1) | CO2021014694A2 (ru) |
| EC (1) | ECSP21079178A (ru) |
| GB (1) | GB2598494A (ru) |
| IL (1) | IL287099A (ru) |
| MX (1) | MX2021013111A (ru) |
| PE (1) | PE20220400A1 (ru) |
| SG (1) | SG11202110646PA (ru) |
| WO (1) | WO2020234300A1 (ru) |
| ZA (1) | ZA202106883B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3174599A1 (en) | 2020-04-09 | 2021-10-14 | Robert Schlegl | Improvements in vaccine formulations for medical use |
| JP2023544834A (ja) | 2020-10-09 | 2023-10-25 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 融合前安定化ｈｍｐｖ ｆタンパク質 |
| WO2022103967A1 (en) | 2020-11-13 | 2022-05-19 | Icosavax, Inc. | Protein-based nanoparticle vaccine for metapneumovirus |
| EP4319802A2 (en) | 2021-04-09 | 2024-02-14 | Valneva SE | Human metapneumovirus combination vaccine |
| WO2023110618A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6194388B1 (en) | 1994-07-15 | 2001-02-27 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| DE60100814T2 (de) | 2000-06-08 | 2004-07-01 | Intercell Biomedizinische Forschungs- Und Entwicklungs Gmbh | Immunstimulierende oligodeoxynukleotide |
| JP2004506019A (ja) | 2000-08-17 | 2004-02-26 | インターツェル・アクチェンゲゼルシャフト | 少なくとも１つの抗原およびカテリシジン由来の抗菌ペプチドまたはその誘導体を含むワクチン |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| US8715922B2 (en) * | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| AU2002320762B2 (en) | 2001-05-21 | 2006-09-21 | Intercell Ag | Immunostimulatory oligodeoxynucleic molecules |
| WO2003047602A1 (en) | 2001-12-07 | 2003-06-12 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
| EP2494987A1 (en) * | 2003-04-25 | 2012-09-05 | MedImmune Vaccines, Inc. | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| EP3269386B1 (en) | 2011-12-06 | 2022-09-14 | Valneva Austria GmbH | Aluminium compounds for use in therapeutics and vaccines |
| US10420834B2 (en) * | 2014-12-24 | 2019-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant metapneumovirus F proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
-
2020
- 2020-05-19 PE PE2021001766A patent/PE20220400A1/es unknown
- 2020-05-19 CA CA3138064A patent/CA3138064A1/en active Pending
- 2020-05-19 JP JP2021564088A patent/JP2022533318A/ja active Pending
- 2020-05-19 BR BR112021021637A patent/BR112021021637A2/pt unknown
- 2020-05-19 GB GB2114836.6A patent/GB2598494A/en active Pending
- 2020-05-19 AU AU2020277661A patent/AU2020277661A1/en active Pending
- 2020-05-19 KR KR1020217034461A patent/KR20220010478A/ko unknown
- 2020-05-19 CN CN202080030901.9A patent/CN114127101A/zh active Pending
- 2020-05-19 SG SG11202110646PA patent/SG11202110646PA/en unknown
- 2020-05-19 EP EP20726137.1A patent/EP3972639A1/en active Pending
- 2020-05-19 US US17/606,811 patent/US20220185847A1/en active Pending
- 2020-05-19 MX MX2021013111A patent/MX2021013111A/es unknown
- 2020-05-19 WO PCT/EP2020/063973 patent/WO2020234300A1/en active Application Filing
-
2021
- 2021-09-17 ZA ZA2021/06883A patent/ZA202106883B/en unknown
- 2021-10-07 IL IL287099A patent/IL287099A/en unknown
- 2021-10-25 EC ECSENADI202179178A patent/ECSP21079178A/es unknown
- 2021-10-26 CL CL2021002819A patent/CL2021002819A1/es unknown
- 2021-10-29 CO CONC2021/0014694A patent/CO2021014694A2/es unknown
-
2023
- 2023-10-24 US US18/493,004 patent/US20240067681A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11229694B2 (en) | Vaccine against RSV | |
| ES2258796T3 (es) | Proteinas de fusion que contienen proteinas de estres para inducir respuestas inmunitarias. | |
| EP0276014B1 (en) | Anticoagulant peptides | |
| JP2015512876A5 (ru) | ||
| RU2021132097A (ru) | Белки rsv f в предшествующей слиянию конформации и их применение | |
| GB2598494A (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP2008504012A5 (ru) | ||
| WO2021249116A9 (en) | Coronavirus vaccine compositions, methods, and uses thereof | |
| RU2000109305A (ru) | ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР) | |
| DE60125751D1 (de) | Zusammensetzungen und verfahren zur behinderung der vervielfältigung von hiv-1 | |
| EP0291981B1 (en) | Cyclic anticoagulant peptides | |
| EP0291982B1 (en) | Cyclic anticoagulant peptides | |
| JPWO2020234300A5 (ru) | ||
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| RU2010140443A (ru) | Применение коньюгатов интерлейкина-1 в лечении диабета | |
| WO2021249013A9 (en) | Vaccine compositions, methods, and uses thereof | |
| JP2899430B2 (ja) | 安定化されたヒルディンのスルホネ−ト、サルフェ−ト、ホスホネ−ト、及びホスフェ−ト誘導体 | |
| RU2021128047A (ru) | Субъединичная вакцина для лечения или предотвращения инфекции дыхательных путей | |
| CN1043134A (zh) | 肽类抗凝剂 | |
| AU640502B2 (en) | Analogs of hirudin having antiplatelet activity | |
| JPWO2019222682A5 (ru) | ||
| US11998597B2 (en) | Vaccine against RSV | |
| US5192745A (en) | Cyclic anticoagulant peptides | |
| RU2020141586A (ru) | Способы лечения гемофилии a | |
| JPWO2021112235A5 (ru) |